Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
CDO
0.58%
$1.72
$1.72
CADENCE OPPORTUNITIES FUND LIMITED. - Charts / Financials
Market Cap $27.23M
!
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.20pm 10/05/2024 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $1.72 | Day High | $1.74 | Day Low | $1.72 | |||
| Daily Volume | 64768 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 1 | $1.70 | 4000 | 1 | $1.75 | 1800 | |
Directors & Senior Management
| Mr. Karl Peter John Siegling | Non-Independent Chairman of the Board |
| Mr. Wayne Davies | Non-Executive Director and Company Secretary |
| Ms. Jolanta Masojada | Non-Executive Independent Director |
| Ms. Susan Oakes | Non-Executive Independent Director |
Data source: Refinitiv
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.010(0.58%) |
Mkt cap ! $27.23M | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.72 | $112.2K | 64.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 1800 | 1 |
View Market Depth
| Last trade - 15.29pm 10/05/2024 (20 minute delay) ? |
| CDO (ASX) Chart |
